Tuesday, October 15, 2019

FW: (LML) Single-dose rifampicin PEP increased the risk of MB disease

 

Leprosy Mailing List – October 15,  2019


Ref.:    (LML) Single-dose rifampicin PEP increased the risk of MB disease

From:  Cairns Smith, Aberdeen, UK


Dear Pieter,

 

I would like to briefly respond to the point raised by Geoff Warne (LML, October 9, 2019).  While I understand why he suggests these discussions should be published in a scientific journal, the reality is that no serious scientific journal is likely to publish such material.  These analyses would be deemed as 'post hoc analysis', 'subgroup analysis', or more crudely as 'data dredging' by critics creating spurious results. 

Cairns Smith

University of Aberdeen, Scotland


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/f9c4fbae-6cb9-4d47-bc1e-e23d918b1bb4%40googlegroups.com.

No comments: